Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | MRNA |
---|---|---|
09:32 ET | 145734 | 63.3099 |
09:34 ET | 30056 | 63.2733 |
09:36 ET | 30339 | 63.3551 |
09:38 ET | 14896 | 63.4699 |
09:39 ET | 31299 | 63.0501 |
09:41 ET | 33749 | 62.97 |
09:43 ET | 20436 | 62.82 |
09:45 ET | 34832 | 62.8 |
09:48 ET | 27368 | 62.77 |
09:50 ET | 19557 | 62.86 |
09:52 ET | 53024 | 63.17 |
09:54 ET | 15054 | 63.08 |
09:56 ET | 14195 | 63.015 |
09:57 ET | 25558 | 62.975 |
09:59 ET | 13834 | 62.87 |
10:01 ET | 8398 | 62.905 |
10:03 ET | 12144 | 63.23 |
10:06 ET | 31310 | 63.15 |
10:08 ET | 15930 | 63.21 |
10:10 ET | 17715 | 63.16 |
10:12 ET | 10448 | 63.25 |
10:14 ET | 12468 | 63.35 |
10:15 ET | 13431 | 63.14 |
10:17 ET | 29233 | 62.93 |
10:19 ET | 7210 | 63.245 |
10:21 ET | 6188 | 63.13 |
10:24 ET | 11787 | 63.02 |
10:26 ET | 8964 | 63 |
10:28 ET | 9262 | 63.01 |
10:30 ET | 13391 | 63.2346 |
10:32 ET | 79104 | 62.995 |
10:33 ET | 6786 | 63.19 |
10:35 ET | 8872 | 63.02 |
10:37 ET | 5906 | 63.05 |
10:39 ET | 11492 | 63.2 |
10:42 ET | 20028 | 63.48 |
10:44 ET | 8941 | 63.52 |
10:46 ET | 13065 | 63.5839 |
10:48 ET | 22148 | 63.4101 |
10:50 ET | 3917 | 63.41 |
10:51 ET | 8672 | 63.57 |
10:53 ET | 8150 | 63.355 |
10:55 ET | 4149 | 63.3 |
10:57 ET | 11918 | 63.28 |
11:00 ET | 7599 | 63.3 |
11:02 ET | 9806 | 63.42 |
11:04 ET | 12631 | 63.4728 |
11:06 ET | 10359 | 63.515 |
11:08 ET | 6407 | 63.43 |
11:09 ET | 11646 | 63.12 |
11:11 ET | 36406 | 63.1376 |
11:13 ET | 14401 | 63.03 |
11:15 ET | 13586 | 63.075 |
11:18 ET | 9188 | 63.14 |
11:20 ET | 8983 | 63.31 |
11:22 ET | 8164 | 63.345 |
11:24 ET | 9786 | 63.24 |
11:26 ET | 3948 | 63.19 |
11:27 ET | 12602 | 63.175 |
11:29 ET | 12299 | 63.2 |
11:31 ET | 12855 | 63.275 |
11:33 ET | 20813 | 63.25 |
11:36 ET | 18558 | 63.28 |
11:38 ET | 6127 | 63.3344 |
11:40 ET | 15935 | 63.19 |
11:42 ET | 17003 | 63.03 |
11:44 ET | 20207 | 63.08 |
11:45 ET | 6134 | 63.11 |
11:47 ET | 7389 | 63.11 |
11:49 ET | 5513 | 63.16 |
11:51 ET | 8158 | 63.1351 |
11:54 ET | 6832 | 63.13 |
11:56 ET | 3469 | 63.09 |
11:58 ET | 9389 | 63.15 |
12:00 ET | 3920 | 63.18 |
12:02 ET | 11838 | 63.27 |
12:03 ET | 3600 | 63.33 |
12:05 ET | 5741 | 63.214 |
12:07 ET | 9467 | 63.28 |
12:09 ET | 8782 | 63.31 |
12:12 ET | 21255 | 63.385 |
12:14 ET | 9128 | 63.525 |
12:16 ET | 16427 | 63.515 |
12:18 ET | 8375 | 63.4 |
12:20 ET | 19140 | 63.31 |
12:21 ET | 6746 | 63.25 |
12:23 ET | 12814 | 63.2601 |
12:25 ET | 7072 | 63.3644 |
12:27 ET | 6379 | 63.4 |
12:30 ET | 1504 | 63.34 |
12:32 ET | 3165 | 63.22 |
12:34 ET | 9322 | 63.143082 |
12:36 ET | 8736 | 63.1087 |
12:38 ET | 7838 | 63.1197 |
12:39 ET | 4100 | 63.17 |
12:41 ET | 3500 | 63.16 |
12:43 ET | 5728 | 63.12 |
12:45 ET | 15009 | 63.04 |
12:48 ET | 24191 | 63.035 |
12:50 ET | 5231 | 63.06 |
12:52 ET | 11129 | 62.95 |
12:54 ET | 8491 | 62.968 |
12:56 ET | 3131 | 63.0399 |
12:57 ET | 12264 | 63 |
12:59 ET | 15378 | 62.89 |
01:01 ET | 20408 | 62.93 |
01:03 ET | 8605 | 62.8682 |
01:06 ET | 23026 | 62.765 |
01:08 ET | 13599 | 62.77 |
01:10 ET | 39537 | 62.7499 |
01:12 ET | 21882 | 62.655 |
01:14 ET | 18530 | 62.58 |
01:15 ET | 17817 | 62.65 |
01:17 ET | 10926 | 62.7235 |
01:19 ET | 4952 | 62.735 |
01:21 ET | 12671 | 62.88 |
01:24 ET | 10398 | 62.85 |
01:26 ET | 6578 | 62.93 |
01:28 ET | 9700 | 62.996676 |
01:30 ET | 22475 | 63.05 |
01:32 ET | 8766 | 63.075 |
01:33 ET | 8696 | 63.13 |
01:35 ET | 16553 | 63.02 |
01:37 ET | 9249 | 63.09 |
01:39 ET | 15133 | 63.205 |
01:42 ET | 10300 | 63.2201 |
01:44 ET | 9399 | 63.195 |
01:46 ET | 3332 | 63.23 |
01:48 ET | 3023 | 63.2653 |
01:50 ET | 7995 | 63.39 |
01:51 ET | 9408 | 63.4 |
01:53 ET | 8360 | 63.469 |
01:55 ET | 12138 | 63.555 |
01:57 ET | 6878 | 63.485 |
02:00 ET | 8358 | 63.34 |
02:02 ET | 4270 | 63.36 |
02:04 ET | 1806 | 63.38 |
02:06 ET | 4030 | 63.4 |
02:08 ET | 14408 | 63.265 |
02:09 ET | 2400 | 63.26 |
02:11 ET | 5223 | 63.275 |
02:13 ET | 6633 | 63.27 |
02:15 ET | 10209 | 63.15 |
02:18 ET | 6345 | 63.17 |
02:20 ET | 16773 | 63.23 |
02:22 ET | 8431 | 63.11 |
02:24 ET | 7112 | 63.15 |
02:26 ET | 9303 | 63.17 |
02:27 ET | 8627 | 63.09 |
02:29 ET | 22610 | 63.05 |
02:31 ET | 8052 | 63.065 |
02:33 ET | 11190 | 63.185 |
02:36 ET | 7290 | 63.2924 |
02:38 ET | 9094 | 63.245 |
02:40 ET | 5043 | 63.2 |
02:42 ET | 4035 | 63.24 |
02:44 ET | 10382 | 63.32 |
02:45 ET | 2263 | 63.32 |
02:47 ET | 13451 | 63.345 |
02:49 ET | 11697 | 63.47 |
02:51 ET | 8319 | 63.436 |
02:54 ET | 14022 | 63.31 |
02:56 ET | 10525 | 63.27 |
02:58 ET | 6475 | 63.19 |
03:00 ET | 7874 | 63.25 |
03:02 ET | 6184 | 63.32 |
03:03 ET | 5622 | 63.245 |
03:05 ET | 5353 | 63.25 |
03:07 ET | 6960 | 63.27 |
03:09 ET | 4382 | 63.32 |
03:12 ET | 5648 | 63.28 |
03:14 ET | 7478 | 63.1978 |
03:16 ET | 8950 | 63.19 |
03:18 ET | 8547 | 63.1304 |
03:20 ET | 8541 | 63.04 |
03:21 ET | 11695 | 63.03 |
03:23 ET | 10303 | 63.02 |
03:25 ET | 9090 | 63.08 |
03:27 ET | 8012 | 63.06 |
03:30 ET | 7858 | 63.115 |
03:32 ET | 11049 | 63.125 |
03:34 ET | 13793 | 63.1075 |
03:36 ET | 15228 | 63.17 |
03:38 ET | 10506 | 63.17 |
03:39 ET | 8462 | 63.17 |
03:41 ET | 10149 | 63.11 |
03:43 ET | 24588 | 63.06 |
03:45 ET | 19713 | 63.065 |
03:48 ET | 10211 | 63.2201 |
03:50 ET | 11496 | 63.21 |
03:52 ET | 16511 | 63.095 |
03:54 ET | 17705 | 63.045 |
03:56 ET | 24092 | 63.08 |
03:57 ET | 54694 | 63.15 |
03:59 ET | 430677 | 63.16 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Moderna Inc | 24.3B | -4.1x | --- |
ICON PLC | 24.4B | 34.2x | +4.68% |
Biontech SE | 28.3B | -51.4x | --- |
Biogen Inc | 27.5B | 23.8x | -18.14% |
Grifols SA | 7.1B | 36.2x | --- |
Beigene Ltd | 26.3B | -46.0x | --- |
Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $24.3B |
---|---|
Revenue (TTM) | $5.1B |
Shares Outstanding | 384.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.67 |
EPS | $-15.37 |
Book Value | $36.27 |
P/E Ratio | -4.1x |
Price/Sales (TTM) | 4.8 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -91.78% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.